Bowel disease patients to march on PHARMAC and Parliament to present 30,000+ signature petition

27 November 2020 - On 2 December 2020, Crohn’s and Colitis NZ will lead a march of patients, supporters and medical ...

Read more →

'Disappointing' delay for new type 2 diabetes drugs that stop kidney failure and save lives

24 November 2020 - Kim Dennis is one of few New Zealanders who knows what it’s like to manage their ...

Read more →

GPs frustrated by PHARMAC’s lack of progress on better meds for type 2 diabetics

24 November 2020 - PHARMAC has put the brakes on two new medications that would greatly improve treatment options for ...

Read more →

Woman trying to raise $110,000 a month for life-extending breast cancer treatment

23 November 2020 - “Pay up or die” is the choice for a woman in her 30s trying to raise ...

Read more →

Ethinyloestradiol 20 mcg with desogestrel 150 mcg and 7 inert tablets (Mercilon 28)

23 November 2020 - Ethinyloestradiol 20 mcg with desogestrel 150 mcg and 7 inert tablets (Mercilon 28) will be fully funded ...

Read more →

Funding changes to dornase alfa for cystic fibrosis

23 November 2020 - From 1 December 2020 dornase alfa will be listed in the Community and the Hospital Medicines List ...

Read more →

Device vital for monitoring diabetes should be funded 'immediately'

23 November 2020 - Ben Hoy and Anne Marie Guiney would not be able to cope with having two type ...

Read more →

PHARMAC and Diabetes Foundation Aotearoa locked in stand-off over drug funding decision

17 November 2020 - The Diabetes Foundation Aotearoa is calling on drug funding agency PHARMAC to release the submissions it ...

Read more →

New drug gives 'normal life' to haemophiliac who thought he would never study, surf or be on stage

15 November 2020 - Performing on stage, going to university and surfing are things Andrew Scott never thought he would ...

Read more →

PHARMAC won’t release the data that changed its mind on diabetes

13 November 2020 - Diabetes Foundation Aotearoa will request the Ombudsman investigate the refusal by PHARMAC to release public submissions ...

Read more →

Proposal to widen access to valganciclovir for transplant patients

12 November 2020 - PHARMAC is seeking feedback on a proposal to widen access to valganciclovir. ...

Read more →

Decision to widen access to treatments for juvenile idiopathic arthritis

11 November 2020 - PHARMAC is pleased to announce a decision to widen access to adalimumab and etanercept for the ...

Read more →

PHARMAC to fund new haemophilia medicine

11 November 2020 - From 1 December 2020 a new medicine will be funded by PHARMAC which will help some people ...

Read more →

COVID-19: Pfizer vaccine could roll out in New Zealand at the start of 2021 if success continues

10 November 2020 - New Zealand researchers are hopeful and optimistic as Pfizer and BioNTech report success in their COVID-19 ...

Read more →

Update on proposal to fund two new medicines for type 2 diabetes mellitus

5 November 2020 - PHARMAC would like to thank everyone who provided feedback on a proposal to fund two new medicines, ...

Read more →